Company attributes
Venture Capital Firm attributes
Other attributes
Mitsubishi UFJ Capital is the venture capital arm of the Mitsubishi UFJ Financial Group, founded in 1974. Mitsubishi UFJ Capital uses the networks and resources of the MUFG Group to assist venture startups in growing their business. Based in Tokyo, Japan, the firm invests in sectors such as infrastructure technology, electronics, biotechnology and healthcare.
Mitsubishi UFJ Capital's investments include UniFa, AuB, ActEvolve, Kyash, HoloEyes, Asilla, proteanTecs and Modulated Imaging.
They exited their investments in Kyriba, Uzabase, Gengo, RareJob, Humanigen, NeoPhotonics, iPierian, ObjectVideo and Cara Therapeutics.
Mitsubishi UFJ Capital has raised a total of ¥20B across 2 funds, their latest being Mitsubishi UFJ Life Science I. This fund was announced on Feb 20, 2017 and raised a total of ¥10B.
